{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:11:45Z","timestamp":1781716305134,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1120084"],"award-info":[{"award-number":["OPP1120084"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T12:50:23Z","timestamp":1686833423000},"page":"4541-4553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1873-1867","authenticated-orcid":false,"given":"Thanyawee","family":"Puthanakit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-4600","authenticated-orcid":false,"given":"Kulkanya","family":"Chokephaibulkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-7436","authenticated-orcid":false,"given":"Surasith","family":"Chaithongwongwatthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-5028","authenticated-orcid":false,"given":"Niranjan","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-5537","authenticated-orcid":false,"given":"Suvaporn","family":"Anugulruengkitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchit","family":"Chayachinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0529-2930","authenticated-orcid":false,"given":"Sanitra","family":"Anuwutnavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4513-5924","authenticated-orcid":false,"given":"Keswadee","family":"Lapphra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supattra","family":"Rungmaitree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monta","family":"Tawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indah","family":"Andi-Lolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6695-5382","authenticated-orcid":false,"given":"Renee","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Librada","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chawanee","family":"Kerdsomboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilasinee","family":"Yuwaree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Hong","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1753-7248","authenticated-orcid":false,"given":"Bruce L.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.vaccine.2023.06.001_b0005","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1093\/infdis\/jiaa469","article-title":"Pertussis (whooping cough)","volume":"224","author":"Decker","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.001_b0010","first-page":"433","article-title":"Pertussis vaccines: WHO position paper - August 2015","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2023.06.001_b0015","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study","volume":"36","author":"Saul","year":"2018","journal-title":"Vaccine"},{"issue":"suppl 4","key":"10.1016\/j.vaccine.2023.06.001_b0020","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw530","article-title":"Assessing the evidence for maternal pertussis immunization: A report from the Bill & Melinda Gates Foundation symposium on pertussis infant disease burden in low- and lower-middle-income countries","volume":"63","author":"Sobanjo-ter Meulen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.001_b0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/AOG.0000000000003161","article-title":"Maternal immunization","volume":"133","author":"Munoz","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.06.001_b0030","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.06.001_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.06.001_b0040","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.06.001_b0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.22.30545","article-title":"A case-control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016","volume":"22","author":"Bellido-Blasco","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2023.06.001_b0050","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2016.03.049","article-title":"Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011\u20132015","volume":"34","author":"Moro","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.001_b0055","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.vaccine.2021.10.076","article-title":"A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age","volume":"40","author":"Chokephaibulkit","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.001_b0060","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1016\/j.vaccine.2020.10.070","volume":"38","author":"Fortuna","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.001_b0065","unstructured":"World_Health_Organization. Annex 4. Recommendations to assure the quality, safety and efficacy of acellular pertussis vaccines. Replacement of Annex 2 of WHO Technical Report Series, No. 878. WHO Technical Report Series No. 979. Available from:https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/vaccine-standardization\/pertussis\/trs_979_annex_4.pdf, 2013."},{"key":"10.1016\/j.vaccine.2023.06.001_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100976","article-title":"Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines","volume":"37","author":"Pitisuttithum","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2023.06.001_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-1157(85)80034-2","article-title":"The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells","volume":"13","author":"Gillenius","year":"1985","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2023.06.001_b0080","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, corrected version 2.1, July 2017."},{"key":"10.1016\/j.vaccine.2023.06.001_b0085","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Harmonised Tripartite Guideline. Clinical safety data management: Definitions and standards for expedited reporting E2A,1994. Available from: http:\/\/fercsl.lk\/wp\/wp-content\/uploads\/2019\/04\/Clinical-Safety-Data-Management-Definitions-Standards-for-Expedited-Reporting-ICH-Harmonised-Tripartite-Guideline-1994.pdf."},{"key":"10.1016\/j.vaccine.2023.06.001_b0090","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.vaccine.2020.01.074","article-title":"Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women","volume":"38","author":"Sompagdee","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.001_b0095","doi-asserted-by":"crossref","unstructured":"Giles ML, Davey MA, Wallace EM. Associations between maternal immunisation and reduced rates of preterm birth and stillbirth: A population based retrospective cohort study. Front Immunol. 2021; 12:704254. doi:10.3389\/fimmu.2021.704254. eCollection 2021.","DOI":"10.3389\/fimmu.2021.704254"},{"key":"10.1016\/j.vaccine.2023.06.001_b0100","doi-asserted-by":"crossref","first-page":"E349","DOI":"10.9778\/cmajo.20200239","article-title":"Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: A retrospective cohort study","volume":"9","author":"Fakhraei","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.vaccine.2023.06.001_b0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cid\/ciz778","article-title":"Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: A randomized trial","volume":"71","author":"Wanlapakorn","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.001_b0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijgo.13456","article-title":"FIGO Statement: Vaccination in pregnancy","volume":"152","author":"Nassar","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.vaccine.2023.06.001_b0115","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jinf.2021.08.022","article-title":"Effectiveness of maternal pertussis vaccination in protecting newborn: A matched case-control study","volume":"83","author":"Godoy","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2023.06.001_b0120","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.vaccine.2021.07.052","article-title":"Pertussis immunisation during pregnancy: Antibody levels and the impact of booster vaccine","volume":"39","author":"Garlasco","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.001_b0125","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1186\/s12889-021-12198-2","article-title":"Vaccination in pregnancy against pertussis and seasonal influenza: key learnings and components from high-performing vaccine programmes in three countries: the United Kingdom, the United States and Spain","volume":"21","author":"Ba\u00efssas","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2023.06.001_b0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4161\/hv.34364","article-title":"Current perspectives on epidemiology and prevention","volume":"11","author":"Gabutti","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.06.001_b0135","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1542\/peds.108.6.e115","article-title":"Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine","volume":"108","author":"Taranger","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.06.001_b0140","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.vaccine.2004.03.046","article-title":"Impact of routine vaccination with a pertussis toxoid vaccine in Denmark","volume":"22","author":"Hviid","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.001_b0145","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/infdis\/jiy022","article-title":"Maternal vaccination with a monocomponent pertussis toxoid vaccine is sufficient to protect infants in a baboon model of whooping cough","volume":"217","author":"Kapil","year":"2018","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:08Z","timestamp":1759404488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23006576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":29,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23006576"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}